TCI Wealth Advisors’s Cabaletta Bio CABA Stock Holding History

TCI Wealth Advisors’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50	Closed	–	–	2389
2021 Q2	$0	Buy	+50	New	+$491	﹤0.01%	2327

Other funds holding CABA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCI Wealth Advisors's CABA Position: Q3 2021 in Review

TCI Wealth Advisors sold out of Cabaletta Bio (CABA) in Q3 2021, closing a stake of 50 shares.

TCI Wealth Advisors first reported a position in CABA in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 61 funds tracked by Wall St. Rank hold CABA as of Q3 2021.

TCI Wealth Advisors reported no remaining Cabaletta Bio position as of Q3 2021 after selling out during the quarter.
TCI Wealth Advisors sold 50 Cabaletta Bio shares in Q3 2021.
TCI Wealth Advisors first reported a position in Cabaletta Bio in Q2 2021 and held it in 1 quarter.
TCI Wealth Advisors's Cabaletta Bio position peaked at $0 in Q2 2021.
61 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2021.

Based on TCI Wealth Advisors's 13F filing for Q3 2021, filed 29 Oct 2021.